PhaseV
-
Business & Markets · Startups PhaseV Lands $50M Series A to Supercharge AI for Clinical Development, Backed by Top VCs and Trusted by Leading Pharma Clients
Insider Brief PRESS RELEASE — PhaseV, a leader in AI/ML-driven clinical development, has announced the completion of a $50 million Series A funding round. Co-led by Accel and Insight Partners and with participation of existing investors… -
Business & Markets · Startups PhaseV Raises $15M to Push the Boundaries of ML for Clinical Trial Optimization
The AI economy, every weekday morning
The daily briefing plus the weekly Scale-ups to watch edition. Free, no spam, unsubscribe any time.